Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prospective Study of Multiparametric Renal MRI for CKD Progression (AFiRM).

Kidney international reports·2026
Same author

A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C Trial.

Journal of hepatology·2026
Same author

Fast segmentation with the NextBrain histological atlas.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Real-Time, Inline Quantitative MRI Enabled by Scanner-Integrated Machine Learning: A Proof of Principle With NODDI.

Magnetic resonance in medicine·2026
Same author

The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network.

European journal of nuclear medicine and molecular imaging·2026
Same author

Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

相关实验视频

Updated: Jul 14, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

防止C型肝炎持续存在的保护.

Shruti H Mehta1, Andrea Cox, Donald R Hoover

  • 1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.

Lancet (London, England)
|May 4, 2002
PubMed
概括

之前的型肝炎病毒 (HCV) 感染提供了对病毒持续性的一些保护. 这表明,获得的免疫力可以被疫苗利用来对抗与HCV相关的肝病.

科学领域:

  • 免疫学 免疫学 免疫学
  • 肝病学 肝病学是一种肝病学.
  • 病毒学 病毒学

背景情况:

  • 型肝炎病毒 (HCV) 感染不会赋予绝育免疫力,个人容易再次感染.
  • 黑猩猩先前感染HCV或接种疫苗的病毒载量和持续时间在再暴露后减少.
  • 该研究旨在确定是否可以在人类中建立与HCV相似的保护性免疫力.

研究的目的:

  • 调查以前的型肝炎病毒 (HCV) 感染对随后的HCV暴露和注射毒品使用者的病毒持久性的影响.
  • 评估先前的HCV感染是否会对新感染和持续性病毒病产生一定程度的保护性免疫力.
  • 为开发潜在的针对病毒持久性的HCV疫苗提供信息.

主要方法:

  • 一项涉及注射毒品使用者的队列研究在四个六个月的时间内进行.
  • 参与者被分为两组:没有先前HCV感染的参与者和有已清除HCV感染的参与者.
  • 两组之间对HCV病毒病的发生率和持续性进行了比较,并对风险行为和HIV-1状态进行了调整.

主要成果:

  • 在没有先前感染的参与者中,新的HCV感染的发生率为21%,而在先前感染的参与者中为12%.
  • 患有先前HCV感染的个体患新型病毒病的可能性一半 (HR 0.45),如果HIV-1阴性,患持久性感染 (OR 0.05) 的可能性是12倍,如果HIV-1阴性.

更多相关视频

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

相关实验视频

Last Updated: Jul 14, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

  • 以前感染过的个体中,HCV RNA水平的中位峰值显着较低,HCV在所有HIV-1阳性参与者中持续存在.
  • 结论:

    • 注射毒品使用者表现出高率的HCV感染和病毒持久性.
    • 对HCV病毒持久性的获得免疫是可以实现的,支持疫苗的研究.
    • 疫苗开发有望减少与HCV相关的肝病的全球负担.